Omada Health (OMDA) CFO trades 16,842 shares via option exercises and sales
Rhea-AI Filing Summary
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported option exercises and related share sales in mid-August 2026. He exercised stock options covering 16,842 shares of common stock at exercise prices between $7.68 and $8.28 per share and sold the same total number of shares at weighted average prices around $25 per share. The transactions were made pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026, and include both fully vested options and options vesting monthly over four years.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 16,842 shares ($283K approx. pre-tax spread)
Exercise and Sale
10 txns
Insider
Cook Steven L.
Role
Chief Financial Officer
Sold
16,842 shs ($422K)
Approx. gross sale proceeds
$422K
Approx. exercise cost
$139K
Approx. pre-tax spread
$283K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F4 | 1,607 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 1,607 | $8.28 | $13K |
| Sale | Common Stock F1, F3 | 1,607 | $25.0135 | $40K |
| Exercise | Stock Option (Right to Buy) F1, F4 | 13,499 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F1, F5 | 1,042 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F1, F6 | 694 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 13,499 | $8.28 | $112K |
| Exercise | Common Stock F1 | 1,042 | $8.01 | $8K |
| Exercise | Common Stock F1 | 694 | $7.68 | $5K |
| Sale | Common Stock F1, F2 | 15,235 | $25.0312 | $381K |
Holdings After Transaction:
Stock Option (Right to Buy) — 274,173 shares (Direct);
Common Stock — 187,209 shares (Direct)
Footnotes (6)
- F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
- F2. This transaction was executed in multiple trades at prices ranging from $25.00 to $25.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $25.00 to $25.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. 100% of the shares subject to the option are fully vested and exercisable.
- F5. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- F6. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Key Figures
Shares sold: 16,842 shares
Shares exercised: 16,842 shares
Sale price (Aug 10): $25.0312 per share
+5 more
8 metrics
Shares sold
16,842 shares
Total common shares sold in code S transactions on August 10–11, 2026
Shares exercised
16,842 shares
Total underlying shares from option exercises (code M) converting into common stock
Sale price (Aug 10)
$25.0312 per share
Weighted average price for 15,235-share sale on August 10, 2026
Sale price (Aug 11)
$25.0135 per share
Weighted average price for 1,607-share sale on August 11, 2026
Option exercise price
$8.28 per share
Exercise price for 13,499 and 1,607 option shares expiring July 19, 2031
Option exercise price
$8.01 per share
Exercise price for 1,042 option shares expiring February 8, 2034
Option exercise price
$7.68 per share
Exercise price for 694 option shares expiring January 27, 2035
10b5-1 plan adoption date
March 14, 2026
Date the reporting person adopted the Rule 10b5-1 trading plan
Key Terms
Rule 10b5-1 trading plan, Stock Option (Right to Buy), weighted average price, vesting commencement date, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with underlying Common Stock shares"
weighted average price financial
"The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
vesting commencement date financial
"measured from February 1, 2024 (the "Vesting Commencement Date")"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
fully vested and exercisable financial
"100% of the shares subject to the option are fully vested and exercisable"
FAQ
What did OMDA CFO Steven L. Cook report in this Form 4?
OMDA CFO Steven L. Cook exercised stock options for 16,842 shares and sold 16,842 common shares in transactions dated August 10–11, 2026, according to the insider trading report.
What option exercise prices did the OMDA CFO have in this filing?
The reported option exercises covered 16,842 shares at exercise prices of $8.28, $8.01, and $7.68 per share, converting stock options into Omada Health common stock before the related sales.
Were the OMDA CFO’s transactions under a Rule 10b5-1 trading plan?
Yes. A footnote states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2026, indicating they were pre-arranged under that plan.
What are the vesting terms of the Omada Health (OMDA) options in this report?
One option grant is 100% vested and exercisable, while two others vest at 1/48th of the shares monthly from February 1, 2024 and February 1, 2025, becoming fully vested after four years.
AI-generated analysis. How Rhea-AI works. Not financial advice.
